CJC-1295 (NO DAC) + Ipamorelin Peptide Blend | Growth Hormone Modulation CJC-1295 and Ipamorelin are synergistic peptides designed to support endogenous growth hormone signalling through complementary pathways. CJC-1295 acts as a GHRH analogue, while Ipamorelin functions as a selective ghrelin receptor agonist, together promoting controlled stimulation of growth hormone release. Utilised in advanced research applications, this combination supports investigation into growth hormone dynamics, recovery processes, body composition, and metabolic regulation—offering a balanced approach to studying endocrine function. ________________________________________ Specifications • Form: Lyophilized powder Freeze-dried powder form for stable storage and easy reconstitution. • Quantity: 5 mg CJC-1295 + 5 mg Ipamorelin per vial • 99% Purity – HPLC Tested ________________________________________ Handling & Storage Store in a cool, dry place away from light. Refrigeration required after reconstitution store between 5-8 degrees ________________________________________ Quality Standard Lab Tested and Manufactured under controlled conditions and supplied as research-grade material. ________________________________________ Shipping Express shipping available within Australia.
Related
Related
Related
Related